VNDA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: VNDA Shares Outstanding History and VNDA YTD Return |
VNDA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: VNDA Shares Outstanding History and VNDA YTD Return |
VNDA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+2.24% CAGR Mouse over chart for data details
|
VNDA Stock Price Chart |
About Vanda Pharmaceuticals Inc |
Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications. We show 52 historical shares outstanding datapoints in our VNDA shares outstanding history coverage, used to compute VNDA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VNDA market cap history over the course of time is important for investors interested in comparing VNDA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VNDA versus a peer is one thing; comparing VNDA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VNDA can fluctuate over the course of history. With this page we aim to empower investors researching VNDA by allowing them to research the VNDA market cap history. |
VNDA Current Stock Quote |
Free VNDA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
VNDA Share Performance |
Market Cap Peers |
Vanda Pharmaceuticals (VNDA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
VOR Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.